Company Profile

Chromagen Inc
Profile last edited on: 1/29/19      CAGE:       UEI:

Business Identifier: Gene expression assays: biological assays and detection instrumentation
Year Founded
1992
First Award
1994
Latest Award
2002
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

10449 Roselle Street
San Diego, CA 92121
   (858) 558-1456
   N/A
   N/A
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Chromagen is a biological assay partner develops platform fluorescence technology and screening assay products for pharmaceutical drug discovery. Partnering with Pharma firms like Merck, Chromagen commercialises tests that simultaneously measure the expression of several genes in a single sample making it possible to screen large numbers of chemical compounds for both desirable and undesirable biological activities.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2002 1 NIH $100,000
Project Title: Novel Red Fluorophore for Multiple mRNA Target Detection
1995 1 USDA $55,000
Project Title: Development Of DNA Probes For Detection And Management Of Coccidiosis In Poultry
1994 1 NIH $71,537
Project Title: Fluorescent DNA Probes for Detection of Mycobacteria
1994 1 NIH $71,537
Project Title: Fluorescent DNA probes for detection of mycobacteria

Key People / Management

  Michael J Conrad -- President

  Ray Johnson -- President

  Raymond Johnson

  Yifeng Xiong

Company News

There are no news available.